ANN ARBOR, Mich., April 4, 2008 /PRNewswire/ -- Terumo Cardiovascular
Systems (Terumo CVS) announced yesterday that it is responding to a patent
infringement complaint by Maquet Cardiovascular LLC. The complaint alleges
that Terumo CVS and its parent company, Terumo Corporation, had infringed
on two patents related to the sale of the Terumo(R) VirtuoSaph(TM)
Endoscopic Vein Harvesting System.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )
Terumo CVS states that its policy and its practice are not to infringe
on the valid intellectual property rights of any company. The VirtuoSaph
system is protected by multiple Terumo patents.
"Frankly, we're surprised at this lawsuit as these patents are several
years old and our product has been on the market for more than three years
with great success," says Mark DiClemente, Vice President, Sales, Terumo
Cardiovascular Systems. "Our competitor has only recently entered the
vessel harvesting market through an acquisition."
Terumo CVS has sold the VirtuoSaph system in the United States since
January 2005. The product is also distributed in Japan and Asia by Terumo
Corporation and in Europe by Terumo's European subsidiary.
The VirtuoSaph system is used during coronary artery bypass grafting
(CABG), the most common cardiac surgery procedure. During the procedure,
the surgeon removes a healthy artery or vein from elsewhere in the body,
most often the saphenous vein in the leg, and uses it to route blood around
a blockage in a coronary artery. The VirtuoSaph system allows the surgical
team to remove the saphenous vein using very small incisions. Endoscopic
procedures have been shown to minimize scarring, morbidity and infection
associated with traditional longitudinal incisions.
Terumo Cardiovascular Systems Corporation manufactures and markets
medical devices for the global cardiac surgery and interventional markets.
The company is headquartered in Ann Arbor, Michigan with manufacturing
operations in Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and
Tustin, California. It is one of several subsidiaries of Terumo Corporation
of Japan focused exclusively on the cardiac and vascular markets, including
Terumo Heart Inc., developer of a ventricular assist device. For more
information, visit www.terumo-cvs.com.
Terumo Corporation is a premier global medical device company with
annual sales in excess of 270,000 (million) yen for the year ending March
31, 2007. Founded in 1921, the company develops, manufactures and
distributes world- class medical devices for use in cardiothoracic surgery,
interventional procedures, transfusion medicine, and needle and syringe
SOURCE Terumo Cardiovascular Systems